Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial)
Karl R. Karsch; Melitta B. Preisack; Rainer Baildon; Volker Eschenfelder; David Foley; Eulogio J. Garcia; Martin Kaltenbach; Christoph Meisner; Hans K. Selbmann; Patrick W. Serruys; Man F. Shiu; Martin Sujatta; Raoul Bonan
- 作者Karl R. Karsch; Melitta B. Preisack; Rainer Baildon; Volker Eschenfelder; David Foley; Eulogio J. Garcia; Martin Kaltenbach; Christoph Meisner; Hans K. Selbmann; Patrick W. Serruys; Man F. Shiu; Martin Sujatta; Raoul Bonan
- 卷第28卷
- 期第6期
- 文件大小876.86KB
- 发表时间1996
- DOI10.1016/s0735-1097(96)00343-9
- 页码1437-1443